Sangram Kale
Company: Biosynth
Job title: Head of Peptide Discovery
Seminars:
Session reserved for Navigo Protiens 11:30 am
day: Day 2 - P&T Track AM
Targeted Radiotherapy using CLIPS™ Macrocyclic Peptides: The case of PSV359 2:00 pm
Discovery, development and preclinical study of [²¹²Pb] PSV359 macrocyclic peptide against FAPα protein Targeting tumor receptors with an on-cell macrocyclic peptide screening platform Macrocyclic CLIPS™ peptide discovery and optimization platform for radioligand therapyRead more
day: P&T Track PM